Inactief instrument

Andere talen NexgenRx Inc. Toronto S.E.

Aandelen

NXG

CA65337X1042

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05
Charles Burns Tenders Resignation as Director of NexgenRx Inc	16/05
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/04
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors	29/12
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024	20/12
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21-08-23
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023	15-06-23
NexgenRx's Q1 Profit Falls, Revenue Rises	19-05-23
NexgenRx Inc. Appoints Dave Bennett as New Director	19-05-23
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19-05-23
NexgenRx Swings to Loss in Q4	10-04-23
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	07-04-23
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29-11-22
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022	23-09-22
NexgenRx Announced Q2 2022 Financial Results	19-08-22
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18-08-22
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17-05-22
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	25-03-22
NexgenRx Inc. Announces Dividend, Payable on February 4, 2022	20-01-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NexgenRx Inc. Toronto S.E.

Aandelen

NXG

CA65337X1042

Andere talen

Filters